Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0000904454-14-000069
Filing Date
2014-01-15
Accepted
2014-01-15 15:12:29
Documents
2
Period of Report
2014-01-10

Document Format Files

Seq Description Document Type Size
1 PRIMARY DOCUMENT edgar.html 3  
1 PRIMARY DOCUMENT edgar.xml 3 3733
2 manhard_poa-011014.htm EX-24 10036
  Complete submission text file 0000904454-14-000069.txt   15357
Mailing Address 123 SAGINAW DRIVE 123 SAGINAW DRIVE REDWOOD CITY CA 94063
Business Address 123 SAGINAW DRIVE REDWOOD CITY CA 94063 6503662626
HERON THERAPEUTICS, INC. /DE/ (Issuer) CIK: 0000818033 (see all company filings)

EIN.: 942875566 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O ARDEA BIOSCIENCES, INC. 4939 DIRECTORS PLACE SAN DIEGO CA 92121
Business Address
MANHARD KIMBERLY (Reporting) CIK: 0001202094 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-33221 | Film No.: 14529637